A Novel Solubility-Enhanced Curcumin Formulation Showing Stability and Maintenance of Anticancer Activity

被引:87
作者
Zhang, Fang [1 ]
Koh, Gar Yee [1 ]
Jeansonne, Duane P. [1 ]
Hollingsworth, Javoris [2 ]
Russo, Paul S. [2 ]
Vicente, Graca [2 ]
Stout, Rhett W. [3 ]
Liu, Zhijun [1 ]
机构
[1] Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA
[2] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA
[3] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA
基金
美国国家科学基金会;
关键词
anticancer; curcumin; formulation; nanoparticles; rubusoside; stability; solubility; ENCAPSULATED CURCUMIN; ORAL BIOAVAILABILITY; CANCER-THERAPY; RAT PLASMA; TETRAHYDROCURCUMIN; PHARMACOKINETICS; INHIBITION;
D O I
10.1002/jps.22512
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Curcumin (CUR) is an active food compound, but its insolubility and instability in water contributes to low bioavailability. In this study, the solubility of CUR was enhanced by utilizing the solubilizing properties of rubusoside (RUB). The solubility of CUR in water increased linearly from 61 mu g/mL to 2.318 mg/mL in the presence of RUB ranging from 1% to 10% (w/v). Dynamic light scattering and transmission electron microscopy studies found that CUR and RUB formed CUR-RUB nanoparticle (similar to 8 nm) complexes. The RUB-solubilized CUR was stable in physiological conditions and did not precipitate when diluted or degrade when spray-dried to a completely reconstitutable powder. Furthermore, cell viability assays demonstrated the efficacy of RUB-solubilized CUR against human colon, breast, and pancreatic cancer cell lines. The development of this new solubilized, stable, and biologically active CUR formulation lays the foundation for future bioavailability improvement. (C) 2011 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 100: 2778-2789, 2011
引用
收藏
页码:2778 / 2789
页数:12
相关论文
共 30 条
[1]   Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages [J].
Abe, Y ;
Hashimoto, S ;
Horie, T .
PHARMACOLOGICAL RESEARCH, 1999, 39 (01) :41-47
[2]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[3]   A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95® CG (Biocurcumax™), A Novel Bioenhanced Preparation of Curcumin [J].
Antony, B. ;
Merina, B. ;
Iyer, V. S. ;
Judy, N. ;
Lennertz, K. ;
Joyal, S. .
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (04) :445-449
[4]   Polymeric nanoparticle-encapsulated curcumin (nanocurcumin"): A novel strategy for human cancer therapy" [J].
Bisht S. ;
Feldmann G. ;
Soni S. ;
Ravi R. ;
Karikar C. ;
Maitra A. ;
Maitra A. .
Journal of Nanobiotechnology, 5 (1)
[5]   Aqueous self-assembly of unsymmetric peptide bolaamphiphiles into nanofibers with hydrophilic cores and surfaces [J].
Claussen, RC ;
Rabatic, BM ;
Stupp, SI .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (42) :12680-12681
[6]   Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems [J].
Cui, Jing ;
Yu, Bo ;
Zhao, Yu ;
Zhu, Weiwei ;
Li, Houli ;
Lou, Hongxiang ;
Zhai, Guangxi .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 371 (1-2) :148-155
[7]   Chemopreventive and therapeutic effects of curcumin [J].
Duvoix, A ;
Blasius, R ;
Delhalle, S ;
Schnekenburger, M ;
Morceau, F ;
Henry, E ;
Dicato, M ;
Diederich, M .
CANCER LETTERS, 2005, 223 (02) :181-190
[8]   Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects [J].
Egan, ME ;
Pearson, M ;
Weiner, SA ;
Rajendran, V ;
Rubin, D ;
Glöckner-Pagel, J ;
Canny, S ;
Du, K ;
Lukacs, GL ;
Caplan, MJ .
SCIENCE, 2004, 304 (5670) :600-602
[9]   Safety and Pharmacokinetics of a Solid Lipid Curcumin Particle Formulation in Osteosarcoma Patients and Healthy Volunteers [J].
Gota, Vikram S. ;
Maru, Girish B. ;
Soni, Tejal G. ;
Gandhi, Tejal R. ;
Kochar, Nitin ;
Agarwal, Manish G. .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2010, 58 (04) :2095-2099
[10]   Curcumin has Bright Prospects for the Treatment of Inflammatory Bowel Disease [J].
Hanai, Hiroyuki ;
Sugimoto, Ken .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (18) :2087-2094